key: cord-0875439-dxff9l5i
authors: Vrachatis, Dimitrios A.; Giotaki, Sotiria G.; Giannopoulos, Georgios
title: COVID-19 myocardial injury: We have much more to discover
date: 2020-09-01
journal: Int J Cardiol
DOI: 10.1016/j.ijcard.2020.05.003
sha: eb7156f375ccdce107dff198c6cd6b034c004345
doc_id: 875439
cord_uid: dxff9l5i

nan

We read with great interest the work by Deng Q. et al. who provide valuable, front-line data regarding myocardial injury in Coronavirus Disease -19 (COVID-19) hospitalized patients [1] . Myocardial involvement has been recognized as a component of COVID-19 in a noteworthy proportion of patients (ranging up to 40% of the cases) and has been related to mortality. Indeed, cardio-protection in COVID-19 -regarding both myocardial necrosis and inflammation -is a target of ongoing research [2] . Do myocardial necrosis' biomarkers act as an unpleasant bystander who provides clinicians an early sign of adverse outcomes or are they indicative of direct myocardial involvement? Deng. et al. [1] suggest, that myocardium is mainly hit in a secondary fashion (i.e. oxygen demand/supply in myocardial cell level). Of course, lack of biopsy and/ or MRI data in their cohort is noted as limitation for this argument; however, authors supported this viewpoint on already published autopsy reports [1] . Still, our knowledge on the field changes rapidly. To date, a series of cases proving diverse mechanisms of direct myocardial injury has been published: histological proved virus-positive SARS-CoV-2 myocarditis [3] , virus-negative lymphocytic myocarditis associated with SARS-CoV-2 respiratory infection (clinically presented as reversetakotsubo) [4] and true takotsubo syndrome [5] . These reports do not contradict (but, indeed, are in line) with the findings of Deng et al. [1] , but COVID-19 being a new entity for clinicians and researchers, they do remind us of the Socratic paradox: "The only thing I know is that I know nothing".

The authors report no relationships that could be construed as a conflict of interest.

Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China

The GReek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): rationale and study design

Myocardial localization of coronavirus in COVID-19 cardiogenic shock

Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection

Typical Takotsubo Syndrome Triggered by SARS-CoV-2 Infection

Acknowledgments DV is personally supported by a scholarship from Hellenic Society of Cardiology (Athens, Greece).